Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

May 16, 2026

Notorious Design Group Announces Upcoming Release of Graffiti Artist Trading Card Collection Drop 2

May 16, 2026

$STREAM Surges 50% in 24 Hours as Streamflow Staking Hits 45% APY on Solana

May 16, 2026

Nova Scotia SPCA’s trap, neuter, return program for feral cats runs out of money

May 16, 2026

West Kelowna pizza shop owner says viral ‘prank’ crossed the line

May 16, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Murugan Govindasamy Joins Boon Logic as Strategic Advisor
Press Release

Murugan Govindasamy Joins Boon Logic as Strategic Advisor

By News RoomNovember 4, 20243 Mins Read
Murugan Govindasamy Joins Boon Logic as Strategic Advisor
Share
Facebook Twitter LinkedIn Pinterest Email

CHICAGO, Nov. 04, 2024 (GLOBE NEWSWIRE) — Boon Logic, provider of the world’s fastest AI-based anomaly detection solutions, announced that Murugan Govindasamy has joined the company as a strategic advisor. Govindasamy led the global automated vision inspection (AVI) technology initiatives at Pfizer for 26 years and brings over 30 years of experience in industrial automation to Boon Logic. He will be instrumental in bringing AVIS, Boon Logic’s breakthrough automated vision inspection system, to global manufacturers, starting with the pharmaceutical industry. Boon Logic announced the appointment at PACK EXPO International, taking place Nov. 3-6 in Chicago. 

“By leveraging AVIS to autonomously train on compliant products in as little as 60 minutes, manufacturers can enhance the accuracy and speed of their visual inspections, resulting in better product quality and improved operational efficiency,” said Govindasamy.

AVIS is Boon Logic’s flagship inspection system based on unsupervised machine learning. AVIS autonomously detects anomalies in complex video and image streams with, in many cases, up to 99% accuracy by training on normal product variations, unlike traditional systems that require defect sets. Govindasamy’s expertise will help Boon Logic scale AVIS, allowing pharmaceutical companies to optimize their inspection processes and ensure the highest product quality with unmatched accuracy.

Under Govindasamy’s leadership, AVIS will continue to provide innovative solutions for some of the toughest inspection challenges, including powder and lyophilized products, glass containers, liquid products prone to bubbles, and other difficult to inspect products.

“We are thrilled to have Murugan on board to validate AVIS’s value to the global market,” said Grant Goris, CEO of Boon Logic. “His deep knowledge of automation and visual inspection in the pharmaceutical industry is the perfect match for Boon Logic’s mission to revolutionize how manufacturers approach quality control.”

For more information about AVIS, schedule a demo.

About Boon Logic

Boon Logic’s breakthrough, patented nano-clustering technology for unsupervised machine learning simplifies and accelerates AI development and deployment in visual inspection and preventive maintenance applications. The next-gen Boon Nano algorithm performs anomaly detection, model training and clustering 1,000 times faster than traditional modeling methods that are complex and involve lengthy model training that can take several weeks to several months. Boon Nano reduces the need for highly-skilled, hard-to-find AI talent and allows organizations to leverage the value of AI with their existing subject matter experts. It is flexible, autonomously tuning, training, and running in real-time at the edge or in the cloud. For more information visit https://boonlogic.com. Follow us on LinkedIn, YouTube, and on our blog. 

Media Contact

Elisabeth Grant
Branch Out Public Relations
612-599-7797
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c272373f-2ea2-4967-851e-e93418627a87

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

Notorious Design Group Announces Upcoming Release of Graffiti Artist Trading Card Collection Drop 2

$STREAM Surges 50% in 24 Hours as Streamflow Staking Hits 45% APY on Solana

Jeff Rouse Swim and Sport Center Celebrates 10 Years of Community Impact, Health, and Athletic Achievement

Excimerlight Expands Into North America With Filter-Free 222nm Far-UVC Technology Platform

Crypto News Today: AlphaPepe AI DEX Hits 4,000 Active Users While Ethereum Price Prediction Targets $10,000

Crypto News Today: AlphaPepe Presale Announces $1.22M Raised While Bitcoin Price Prediction Targets $200,000

Educare Network Convenes National Leaders in Tulsa to Reimagine the Future of Early Childhood Education

KPC Health’s Orange County Global Medical Center Raises Donate Life Flag to Honor Organ, Eye, and Tissue Donors

Editors Picks

Notorious Design Group Announces Upcoming Release of Graffiti Artist Trading Card Collection Drop 2

May 16, 2026

$STREAM Surges 50% in 24 Hours as Streamflow Staking Hits 45% APY on Solana

May 16, 2026

Nova Scotia SPCA’s trap, neuter, return program for feral cats runs out of money

May 16, 2026

West Kelowna pizza shop owner says viral ‘prank’ crossed the line

May 16, 2026

Latest News

Jeff Rouse Swim and Sport Center Celebrates 10 Years of Community Impact, Health, and Athletic Achievement

May 15, 2026

Montreal sex workers to go on strike during Grand Prix weekend

May 15, 2026

Lessons from an astronaut: Artemis II crew shares advice on risk, work and friendship

May 15, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version